Pharmafile Logo
Pharmafocus logo
Advanced Search

AstraZeneca and MSD present final results of key secondary overall survival endpoint from Phase III PROpel trial at ASCO GU Cancers Symposium

February 20, 2023
Business Services

Results from the final prespecified overall survival (OS) analysis of the PROpel Phase III trial in metastatic castration-resistant prostate cancer …

News
Press release

SMC recommends Opdivo® (nivolumab) for use post-surgery in specific urothelial cancer patients

February 20, 2023
Business Services

(Uxbridge, Middlesex, 13 February 2023) – The Scottish Medicines Consortium (SMC) has accepted Bristol Myers Squibb’s (BMS’) nivolumab for the …

News
Press release

Cabometyx® in combination with nivolumab shows durable survival benefits at over three-years’ follow-up in first-line advanced renal cell carcinoma

February 20, 2023
Business Services

PARIS, FRANCE, STRICTLY EMBARGOED until 11.00pm CET, 13 February 2023 – Ipsen (Euronext: IPN; ADR: IPSEY) today announced three-year minimum, …

Feature
Case study

Janssen Presents Updated Data Demonstrating Improved Outcomes from the Use of Niraparib in Combination with Abiraterone Acetate Plus Prednisone as a First-Line Therapy in Patients with BRCA-Positive Metastatic CastrationResistant Prostate Cance

February 20, 2023
Business Services

BEERSE, BELGIUM, 16 February 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced updated results from the …

News
Press release
david-travis-avvzjc0ynbq-unsplash

FDA approves Apellis’ geographic atrophy treatment

February 20, 2023
Medical Communications

Apellis’ Syfovre (pegcetacoplan injection) is indicated for patients with geographic atrophy (GA) with or without subfoveal involvement, and has received …

News

Medtronic’s extravascular defibrillator receives CE mark

February 20, 2023
Medical Communications

Medtronic has received CE mark for its extravascular defibrillator. The Aurora EV-ICD™ MRI SureScan™ and Epsila EV™ MRI SureScan™ defibrillation …

News

Pfizer’s Lyme disease vaccine study cut due to protocol violations

February 20, 2023
Medical Communications

Valneva and Pfizer have seen their Lyme disease vaccine study cut down after some clinical trial sites were revealed to …

News

Stryker’s Q Guidance System received FDA clearance for cranial applications

February 20, 2023
Sales and Marketing

Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from …

News

Sun Pharma recalls at least 34,000 bottles of generic drug

February 13, 2023
Medical Communications

Mumbai-based pharma company, Sun Pharma, has announced that it is recalling over 34,000 bottles of a generic drug, Diltiazem Hydrochloride, …

News

REGENXBIO presents interim phase 2 data from drug developed on NAVXpress™ platform

February 13, 2023
Manufacturing and Production

REGENXBIO, a clinical-stage biotech company, has announced positive phase 2 data for their drug RXG-314, which was developed by the …

News

Scancell shares “highly encouraging” results from phase 1 COVID-19 vaccine trial

February 13, 2023
Research and Development

Scancell Holdings PLC has shared “highly encouraging” results from its phase 1 clinical trial of its COVID-19 vaccines, says chief …

News

Sorrento Therapeutics’ subsidiary Scilex Holding Company acquires rights to acute migraine treatment

February 13, 2023
Sales and Marketing

Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, has announced that it has acquired the rights to ELYXYBTM (celecoxib oral …

News

UK pharma packaging giant Origin celebrates its 60th anniversary

February 13, 2023
Business Services

13th FEBRUARY 2023, HULL, UK: Leading UK pharmaceutical packaging and solutions provider, Origin, is celebrating its 60th anniversary.   Origin …

News
Press release

CYDAR MEDICAL RAISES $11.5M (£9.3M) IN SERIES A FUNDING ROUND

February 13, 2023
Business Services

CAMBRIDGE, UNITED KINGDOM, 13 FEBRUARY 2023 – Cydar Medical (“Cydar” or “the Company”) a global, cloud-based surgical software company, announces …

News
Press release

AstraZeneca moves manufacturing to Ireland due to Britain’s tax regime

February 10, 2023
Medical Communications

Big pharma giant, AstraZeneca, has announced that its plans to open a new facility in northwest England have now changed, …

News

SynaptixBio secures FDA Rare Paediatric Disease designation to develop treatments for TUBB4a leukodystrophy

February 10, 2023
Research and Development

SynaptixBio, a UK-based biotech firm, has been granted FDA Rare Paediatric Disease (RPD) designation – an accolade which encourages the …

News

AbbVie expects 37% decline in Humira sales following new biosimilars hitting the US market

February 10, 2023
Sales and Marketing

AbbVie Inc has announced that it expects to see a 37% decline in sales of its flagship rheumatoid arthritis drug …

News

FDA grants full approval to GSK for mismatch repair-deficient endometrial cancer treatment

February 10, 2023
Medical Communications

GSK announced that its treatment for recurrent or advanced mismatch repair-deficient (dMMR) endometrial cancer has been granted full approval by …

News

RQ Bio Strengthens Board with Industry-leading Infectious Disease Experts Joining as Non-Executive Directors

February 9, 2023
Business Services

LONDON, UK, 9 February 2023 — RQ Bio is scaling up at speed, with the appointment of Non-Executive Directors, Dr …

Appointment

Stand Up To Cancer announces four teams dedicated to increasing diversity in clinical trials

February 9, 2023
Medical Communications

Stand Up To Cancer (SU2C) has announced four teams that will focus on increasing diversity in early phase cancer clinical …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026